TFF Pharmaceuticals, Inc.
NASDAQ:TFFP
1.63 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | TFF Pharmaceuticals, Inc. |
Symbool | TFFP |
Munteenheid | USD |
Prijs | 1.63 |
Beurswaarde | 5,649,645 |
Dividendpercentage | 0% |
52-weken bereik | 1.35 - 11 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Harlan F. Weisman |
Website | https://www.tffpharma.com |
An error occurred while fetching data.
Over TFF Pharmaceuticals, Inc.
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)